XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2023 $ 3,069 $ 0 $ 22 $ 1,148 $ 2,554 $ (655)
Beginning balance (in shares) at Dec. 31, 2023     43,902,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income 86       85 1
Common stock dividends declared (32)       (32)  
Common stock issued under employee stock award and stock purchase plans and other (in shares) [1]     378,000      
Common stock issued under employee stock award and stock purchase plans and other [1] $ (17)     (17)    
Common stock repurchases (in shares) (500,000)   (451,000)      
Common stock repurchases $ (51)     (12) (39)  
Share-based compensation 10     10    
Ending balance at Mar. 31, 2024 3,065 0 $ 22 1,129 2,568 (654)
Ending balance (in shares) at Mar. 31, 2024     43,829,000      
Beginning balance at Dec. 31, 2024 $ 3,117 0 $ 21 1,144 2,644 (692)
Beginning balance (in shares) at Dec. 31, 2024 42,080,039   42,080,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Comprehensive income $ 105       98 7
Common stock dividends declared (35)       (35)  
Common stock issued under employee stock award and stock purchase plans and other (in shares) [1]     317,000      
Common stock issued under employee stock award and stock purchase plans and other [1] $ (23)   $ 1 (23) (1)  
Common stock repurchases (in shares) (1,100,000)   (1,056,000)      
Common stock repurchases $ (167)   $ (1) (29) (137)  
Share-based compensation 6     6    
Ending balance at Mar. 31, 2025 $ 3,003 $ 0 $ 21 $ 1,098 $ 2,569 $ (685)
Ending balance (in shares) at Mar. 31, 2025 41,340,792   41,341,000      
[1] Net of common shares delivered as payment for the exercise price or to satisfy the holders' withholding tax liability upon exercise of options.